
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Dirbas, Surgeon in Stanford, CA?
Dr. Frederick Dirbas, MD is a Surgeon, who primarily practices in Stanford, CA. He is board certified. Dr. Dirbas completed his residency at Clinical Ctr At The Nih, Cardiovascular Surgery; Stanford Univ Hosp, General Surgery. Dr. Dirbas is fluent in English and Spanish, and is currently seeing new patients. Dr. Dirbas’s practice accepts Kaiser Permanente, Medicaid, Medicare, Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Dirbas’s office at (650) 723-4000.
What are Areas of Expertise for Dr. Dirbas?
Dr. Frederick Dirbas, MD is a highly-rated, board-certified Surgeon known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Dirbas empowers patients to confidently navigate their health journey, specializing in Breast Cancer, Minimally Invasive Surgery, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Dirbas is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Dirbas go to medical school and complete their residency?
Fellowship: National Institutes of Health
Residency: Clinical Ctr At The Nih, Cardiovascular Surgery; Stanford Univ Hosp, General Surgery | Stanford University School Of Med | Stanford University School of Medicine
Medical School: Columbia Univ Coll of Physicians And Surgeons, New York Ny
Is Dr. Dirbas board certified as a Surgeon?
Yes, Dr. Frederick Dirbas, MD is board certified by the American Board of Surgery
What languages does Dr. Dirbas speak?
Dr. Dirbas and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Surgeon like Dr. Dirbas typically treat?
As a Surgeon, Dr. Dirbas diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Dirbas. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Breast Cancer
- Mammary cancer
- Breast carcinoma
- Breast tumor
- Female Breast Cancer
- Malignant Breast Tumor
- Breast Carcinoma
ICD-10 Codes:
- C50912: Malignant neoplasm of unspecified site of left female breast
- C50919: Malignant neoplasm of unspecified site of unspecified female breast
- C50911: Malignant neoplasm of unspecified site of right female breast
Also known as:
- Personal History of Breast Cancer
- Breast Cancer
- Past breast cancer
- Previous mammary malignancy
- History of breast tumor
ICD-10 Codes:
- Z853: Personal history of malignant neoplasm of breast
What procedures does a Surgeon like Dr. Dirbas typically perform?
As a Surgeon, Dr. Dirbas performs a variety of medical procedures. This procedure information is derived from anonymized insurance claims and highlights the medical procedures most commonly performed by Dr. Dirbas. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Partial Mastectomy
- Simple Mastectomy
- Mastectomy
- Lumpectomy
- Breast conserving surgery
- Quadrantectomy
- Segmentectomy
- Complete Mastectomy
- Breast Removal Surgery
- Total Mastectomy
- Unilateral Mastectomy
CPT Codes:
- 19301: Mastectomy, partial (eg, lumpectomy, tylectomy, quadrantectomy, segmentectomy);
- 19303: Mastectomy, simple, complete
Also known as:
- Breast Lump Removal with Marker Guidance
- Image-Guided Breast Lesion Excision
- Wire-Localized Breast Biopsy
- Open Excision of Marked Breast Lesion
- Breast Mass Removal with Marker
CPT Codes:
- 19125: Excision of breast lesion identified by preoperative placement of radiological marker, open; single lesion
Also known as:
- Breast Tissue Expander Placement
- Breast Reconstruction
- Breast Reconstruction with Expanders
- Tissue Expander Surgery (Breast)
- Breast Implant Preparation
CPT Codes:
- 19357: Tissue expander placement in breast reconstruction, including subsequent expansion(s)
Also known as:
- Biologic Implant for Soft Tissue Reinforcement
- Acellular Dermal Matrix Implant
- Breast Reinforcement Implant
- Trunk Soft Tissue Repair
- Tissue Scaffold Implant
CPT Codes:
- 15777: Implantation of biologic implant (eg, acellular dermal matrix) for soft tissue reinforcement (ie, breast, trunk) (List separately in addition to code for primary procedure)
Also known as:
- Deep Armpit Lymph Node Biopsy
- Biopsy
- Axillary Lymph Node Excision
- Open Axillary Node Biopsy
- Underarm Lymph Node Removal
CPT Codes:
- 38525: Biopsy or excision of lymph node(s); open, deep axillary node(s)
Also known as:
- Sentinel Lymph Node Mapping
- Lymph Node Identification
- Sentinel Node Biopsy (Mapping)
- Dye Injection for Lymph Nodes
CPT Codes:
- 38900: Intraoperative identification (eg, mapping) of sentinel lymph node(s) includes injection of non-radioactive dye, when performed (List separately in addition to code for primary procedure)
Does Dr. Dirbas accept my insurance?
Dr. Dirbas accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Dirbas accept in Stanford, CA?
Dr. Dirbas in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Medicaid
Medicare
Santa Cruz County
State of California
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Dirbas' office located?
Recognitions
Publications
Breast Surgical Techniques and Interdiscipliry Magement
Accelerated Partial Breast Irradiation: Where Do We Stand?
, 2009
Streamlining clinical breast examition
, 2005
Defining an optimal role for bre
, 2013
Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients
, 2013
A Pilot Cohort Study of the Determints of Longitudil Opioid Use After Surgery
, 2012
Toward MR-guided high intensity focused ultrasound for presurgical localization
, 2012
Breast Magnetic Resonce Imaging Alters Patient Selection for Accelerated Partial Breast Irradiation
Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic
, 2010
Freehand MRI-Guided Preoperative Needle Localization of Breast Lesions After MRI-Guided
, 2010
3.0-T MR-Guided Focused Ultrasound for Preoperative Localization of Nonpalpable Breast Lesions
, 2009
Downregulation of miR-200c Links Breast Cancer Stem Cells with Normal Stem Cells
, 2009
Impaired interferon sigling is a common immune defect in human cancer
, 2009
Association of reactive oxygen species levels and radioresistance in cancer stem cells
, 2009
Axillary surgery in breast cancer patients
, 2007
Phyllodes tumors of the breast: tural history, diagnosis, and treatment.
, 2007
Pathologic correlates of false positive breast magnetic resonce imaging findings
, 2005
Rates of reexcision for breast cancer after magnetic resonce imaging
, 2005
Breast magnetic resonce imaging alters patient selection for accelerated
, 2005
Magnetic resonce imaging of suspicious breast masses seen on one mammographic view.
, 2004
Breast magnetic resonce image screening
, 2004
Results from a pilot breast cancer screening trial using a combition of clincal breast exam
, 2003
Clinical magement of breast pain: A review
, 2002
Locally advanced breast cancer: is surgery necessary?
, 2001
Perforated jejul diverticula
, 1996
HUMANIZED ANTIBODY-DIRECTED TO THE IL
, 1994
ANTI-TAC-H, A HUMANIZED ANTIBODY TO THE INTERLEUKIN-2 RECEPTOR
, 1991
DISSEMITED CUTANEOUS HERPES-ZOSTER FOLLOWING CARDIAC-SURGERY
, 1990
CONTROLLED REPERFUSION FOLLOWING REGIOL ISCHEMIA
, 1987
CONTROLLED REPERFUSION OF REGIOL ISCHEMIA
, 1983
Breast Surgical Techniques and Interdisciplinary Management
Accelerated Partial Breast Irradiation: Where Do We Stand?
, 2009
Streamlining clinical breast examination
, 2005
The evolution of accelerated
, 2004
Defining an optimal role for bre
, 2013
Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients
, 2013
PRC2/EED-EZH2 Complex Is Up-Regulated in Breast Cancer
, 2012
A Pilot Cohort Study of the Determinants of Longitudinal Opioid Use After Surgery
, 2012
Toward MR-guided high intensity focused ultrasound for presurgical localization
, 2012
Breast Magnetic Resonance Imaging Alters Patient Selection
Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic
, 2010
Freehand MRI-Guided Preoperative Needle Localization of Breast Lesions After MRI-Guided
, 2010
3.0-T MR-Guided Focused Ultrasound for Preoperative Localization of Nonpalpable Breast Lesions
, 2009
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
, 2009
Impaired interferon signaling is a common immune defect in human cancer
, 2009
Association of reactive oxygen species levels and radioresistance in cancer stem cells
, 2009
New models and online calculator for predicting non
, 2008
New models and online calculator for predicting non
, 2008
Axillary surgery in breast cancer patients
, 2007
Phyllodes tumors of the breast: natural history, diagnosis, and treatment.
, 2007
Impact of increasing margin around the lumpectomy cavity to define the planning target volume
, 2007
Outcomes of women with metachronous breast and ovarian carcinomas
, 2006
Predicting non-sentinel lymph node involvement in breast cancer patients.
, 2006
Pathologic correlates of false positive breast magnetic resonance imaging findings
, 2005
Rates of reexcision for breast cancer after magnetic resonance imaging
, 2005
Breast magnetic resonance imaging alters patient selection for accelerated
, 2005
Magnetic resonance imaging of suspicious breast masses seen on one mammographic view.
, 2004
Breast magnetic resonance image screening
, 2004
A pilot breast cancer screening trial for women at high inherited risk using clinical breast exam
, 2004
Results from a pilot breast cancer screening trial using a combination of clincal breast exam
, 2003
Comprehensive screening using breast MRI and ductal lavage in high-risk women.
, 2002
Clinical management of breast pain: A review
, 2002
Freehand iMRI-guided large-gauge core needle biopsy
, 2001
Locally advanced breast cancer: is surgery necessary?
, 2001
Radiofrequency ablation of breast cancer - First report of an emerging technology
, 1999
Parathyroid localization with high-resolution ultrasound and technetium Tc 99m sestamibi
, 1999
Perforated jejunal diverticula
, 1996
HUMANIZED ANTIBODY-DIRECTED TO THE IL
, 1994
PROLONGATION OF GRAFT-SURVIVAL IN PRIMATE ALLOGRAFT TRANSPLANTATION BY YTTRIUM
, 1992
ANTI-TAC-H, A HUMANIZED ANTIBODY TO THE INTERLEUKIN-2 RECEPTOR
, 1991
DISSEMINATED CUTANEOUS HERPES-ZOSTER FOLLOWING CARDIAC-SURGERY
, 1990
CONTROLLED REPERFUSION FOLLOWING REGIONAL ISCHEMIA
, 1987
CONTROLLED REPERFUSION OF REGIONAL ISCHEMIA
, 1983
EXPERIMENTS ON THE ABIOTIC AMPLIFICATION OF OPTICAL-ACTIVITY
, 1981
STEREOSELECTIVE HYDROLYSIS OF LEUCINE OLIGOMERS
, 1981